Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression Scale (DEPS) in schizophrenia.

J Huttunen1, T Taiminen, J Kähkönen

  • 1Department of Psychiatry, Turku University Central Hospital, Finland.

Acta Psychiatrica Scandinavica
|April 1, 1999
PubMed
Summary

The Depression Scale (DEPS) can effectively screen for depression in schizophrenia patients. While useful, positive DEPS results require confirmation through a clinical interview.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome measures after anterior cervical decompression and fusion surgery -non-respondents do not bias the results: A Finnish spine register (FinSpine) study.

Brain & spine·2025
Same author

Increased Mortality Despite Successful Multifactorial Cardiovascular Risk Reduction in Healthy Men: 40-Year Follow-Up of the Helsinki Businessmen Study Intervention Trial.

The journal of nutrition, health & aging·2018
Same author

Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.

European journal of pain (London, England)·2017
Same author

Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies.

European psychiatry : the journal of the Association of European Psychiatrists·2015
Same author

ViPAR: a software platform for the Virtual Pooling and Analysis of Research Data.

International journal of epidemiology·2015
Same author

Efficacy of stabilisation splint treatment on facial pain - 1-year follow-up.

Journal of oral rehabilitation·2015

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Depression is a common comorbidity in schizophrenia.
  • Accurate screening for depression in schizophrenia is crucial for effective management.
  • Existing screening tools may have limitations in this population.

Purpose of the Study:

  • To evaluate the Depression Scale (DEPS) as a screening tool for depression in patients with schizophrenia.
  • To compare the DEPS with the Calgary Depression Scale (CDS) in this population.

Main Methods:

  • The DEPS was administered to 63 patients diagnosed with schizophrenia.
  • The Calgary Depression Scale (CDS) was used as the gold standard for comparison.

Main Results:

  • The DEPS demonstrated a negative predictive value of 97% for detecting depression in schizophrenia.

Related Experiment Videos

  • The positive predictive value of the DEPS was 41%.
  • A strong correlation (0.73) was observed between total DEPS and CDS scores.

    • Conclusions:

    • The DEPS is a potentially valuable tool for screening depression in individuals with schizophrenia.
    • The DEPS's high negative predictive value suggests it can reliably rule out depression.
    • Clinical interviews remain essential for confirming positive depression diagnoses identified by the DEPS.